Global mRNA therapeutics Market Size study, by Application (Rare genetic diseases, Oncology, Respiratory diseases, Infectious disease and others), By Type (Prophylactic Vaccines, Therapeutic Vaccines and Therapeutic Drugs), By End-User (Hospitals & Clinics, Research Organizations and Others) and Regional Forecasts 2022-2028
Global mRNA therapeutics Market is valued at approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. RNA-based therapies have received a lot of interest in recent years, because of its excellent potential for treating chronic diseases. Furthermore, RNA vaccines have a lot of advantages over DNA vaccines in terms of production, dissemination, and safety. The need for mRNA vaccines and therapies has grown as a result of them showing promise in human clinical investigations. In addition, the popularity of the COVID-19 vaccines developed by Moderna and Pfizer-BioNTech has led to a sharp increase in the number of mRNA-based vaccine treatments being tested in oncology clinical trials. Additionally, 2021 saw the second-highest number of mRNA vaccination trials for cancer patients after the COVID-19 trials, which fueled the industry's expansion. This market expansion is being driven by the increased incidences of rare diseases including propionic acidemia, methylmalonic acidemia, glycogen disease, phenylketonuria, metabolic and immunological disorders as well as chronic diseases like cancer, heart disease, pulmonary, CKD, and others. For instance, according to Globocan, there were 10.6 million cancer-related deaths and 19.3 million new cases of cancer worldwide in December 2020. Additionally, the demand for mRNA vaccines and therapies rises due to the popularity of mRNA vaccines, the development of tailored cancer medicines, and a robust pipeline of new products, which spurs industry growth over the course of the projected period. However, lack of skilled professionals is expected to hamper the market growth in the forthcoming period.
The key regions considered for the global mRNA therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market, and over the projected period, it will grow at the quickest rate. The market in North America will be driven by the availability of sizable research funding, expanding federal programmes for RNA-based therapies, and rising number of clinical studies. For instance, Graham and others' basic research was supported by the National Institutes of Health (NIH), the Defense Department, and federally financed academic laboratories in November 2020. This assistance was a key factor in the rapid discovery of vaccines against COVID-19. The government has given vaccine producers an additional $10.5 billion since the pandemic began in order to speed up the delivery of their goods.
Major market players included in this report are:
MODERNA, INC.
BIONTECH SE
CENTOGENE AG
ARCTURUS THERAPEUTICS
TRANSLATE BIO, INC.
GSK PLC.
ARGOS THERAPEUTICS INC.
SANGAMO THERAPEUTICS, INC.
AVROBIO, Inc.
PFIZER INC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Rare genetic diseases
Oncology
Respiratory diseases
Infectious disease
others
By Type:
Prophylactic Vaccines
Therapeutic Vaccines
Therapeutic Drugs
By End-User:
Hospitals & Clinics
Research Organizations
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global mRNA therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The key regions considered for the global mRNA therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market, and over the projected period, it will grow at the quickest rate. The market in North America will be driven by the availability of sizable research funding, expanding federal programmes for RNA-based therapies, and rising number of clinical studies. For instance, Graham and others' basic research was supported by the National Institutes of Health (NIH), the Defense Department, and federally financed academic laboratories in November 2020. This assistance was a key factor in the rapid discovery of vaccines against COVID-19. The government has given vaccine producers an additional $10.5 billion since the pandemic began in order to speed up the delivery of their goods.
Major market players included in this report are:
MODERNA, INC.
BIONTECH SE
CENTOGENE AG
ARCTURUS THERAPEUTICS
TRANSLATE BIO, INC.
GSK PLC.
ARGOS THERAPEUTICS INC.
SANGAMO THERAPEUTICS, INC.
AVROBIO, Inc.
PFIZER INC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Rare genetic diseases
Oncology
Respiratory diseases
Infectious disease
others
By Type:
Prophylactic Vaccines
Therapeutic Vaccines
Therapeutic Drugs
By End-User:
Hospitals & Clinics
Research Organizations
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global mRNA therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. mRNA therapeutics Market, by region, 2020-2028 (USD Billion)
1.2.2. mRNA therapeutics Market, by Application, 2020-2028 (USD Billion)
1.2.3. mRNA therapeutics Market, by Type, 2020-2028 (USD Billion)
1.2.4. mRNA therapeutics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MRNA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MRNA THERAPEUTICS MARKET DYNAMICS
3.1. MRNA therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Surging geriatric population
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D spending in mRNA therapeutics s
CHAPTER 4. GLOBAL MRNA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL MRNA THERAPEUTICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global mRNA therapeutics Market by Application, Performance - Potential Analysis
6.3. Global mRNA therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
6.4. mRNA therapeutics Market, Sub Segment Analysis
6.4.1. Rare genetic diseases
6.4.2. Oncology
6.4.3. Respiratory diseases
6.4.4. Infectious disease
6.4.5. Others
CHAPTER 7. GLOBAL MRNA THERAPEUTICS MARKET, BY TYPE
7.1. Market Snapshot
7.2. Global mRNA therapeutics Market by Type, Performance - Potential Analysis
7.3. Global mRNA therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
7.4. MRNA therapeutics Market, Sub Segment Analysis
7.4.1. Prophylactic Vaccines
7.4.2. Therapeutic Vaccines
7.4.3. Therapeutic Drugs
CHAPTER 8. GLOBAL MRNA THERAPEUTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global mRNA therapeutics Market by End-User, Performance - Potential Analysis
8.3. Global mRNA therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
8.4. MRNA therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Research Organizations
8.4.3. Others
CHAPTER 9. GLOBAL MRNA THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. mRNA therapeutics Market, Regional Market Snapshot
9.2. North America mRNA therapeutics Market
9.2.1. U.S. mRNA therapeutics Market
9.2.1.1. Application breakdown estimates & forecasts, 2018-2028
9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-202
9.2.2. Canada mRNA therapeutics Market
9.3. Europe mRNA therapeutics Market Snapshot
9.3.1. U.K. mRNA therapeutics Market
9.3.2. Germany mRNA therapeutics Market
9.3.3. France mRNA therapeutics Market
9.3.4. Spain mRNA therapeutics Market
9.3.5. Italy mRNA therapeutics Market
9.3.6. Rest of Europe mRNA therapeutics Market
9.4. Asia-Pacific mRNA therapeutics Market Snapshot
9.4.1. China mRNA therapeutics Market
9.4.2. India mRNA therapeutics Market
9.4.3. Japan mRNA therapeutics Market
9.4.4. Australia mRNA therapeutics Market
9.4.5. South Korea mRNA therapeutics Market
9.4.6. Rest of Asia Pacific mRNA therapeutics Market
9.5. Latin America mRNA therapeutics Market Snapshot
9.5.1. Brazil mRNA therapeutics Market
9.5.2. Mexico mRNA therapeutics Market
9.6. Rest of The World mRNA therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Moderna, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Application Summary
10.2.1.5. Recent Developments
10.2.2. Biontech Se
10.2.3. Centogene Ag
10.2.4. Arcturus Therapeutics
10.2.5. Translate Bio, Inc.
10.2.6. GSK Plc.
10.2.7. Argos Therapeutics Inc.
10.2.8. Sangamo Therapeutics, Inc.
10.2.9. Avrobio, Inc.
10.2.10. Pfizer Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. mRNA therapeutics Market, by region, 2020-2028 (USD Billion)
1.2.2. mRNA therapeutics Market, by Application, 2020-2028 (USD Billion)
1.2.3. mRNA therapeutics Market, by Type, 2020-2028 (USD Billion)
1.2.4. mRNA therapeutics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MRNA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MRNA THERAPEUTICS MARKET DYNAMICS
3.1. MRNA therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Surging geriatric population
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D spending in mRNA therapeutics s
CHAPTER 4. GLOBAL MRNA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL MRNA THERAPEUTICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global mRNA therapeutics Market by Application, Performance - Potential Analysis
6.3. Global mRNA therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
6.4. mRNA therapeutics Market, Sub Segment Analysis
6.4.1. Rare genetic diseases
6.4.2. Oncology
6.4.3. Respiratory diseases
6.4.4. Infectious disease
6.4.5. Others
CHAPTER 7. GLOBAL MRNA THERAPEUTICS MARKET, BY TYPE
7.1. Market Snapshot
7.2. Global mRNA therapeutics Market by Type, Performance - Potential Analysis
7.3. Global mRNA therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
7.4. MRNA therapeutics Market, Sub Segment Analysis
7.4.1. Prophylactic Vaccines
7.4.2. Therapeutic Vaccines
7.4.3. Therapeutic Drugs
CHAPTER 8. GLOBAL MRNA THERAPEUTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global mRNA therapeutics Market by End-User, Performance - Potential Analysis
8.3. Global mRNA therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
8.4. MRNA therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Research Organizations
8.4.3. Others
CHAPTER 9. GLOBAL MRNA THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. mRNA therapeutics Market, Regional Market Snapshot
9.2. North America mRNA therapeutics Market
9.2.1. U.S. mRNA therapeutics Market
9.2.1.1. Application breakdown estimates & forecasts, 2018-2028
9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-202
9.2.2. Canada mRNA therapeutics Market
9.3. Europe mRNA therapeutics Market Snapshot
9.3.1. U.K. mRNA therapeutics Market
9.3.2. Germany mRNA therapeutics Market
9.3.3. France mRNA therapeutics Market
9.3.4. Spain mRNA therapeutics Market
9.3.5. Italy mRNA therapeutics Market
9.3.6. Rest of Europe mRNA therapeutics Market
9.4. Asia-Pacific mRNA therapeutics Market Snapshot
9.4.1. China mRNA therapeutics Market
9.4.2. India mRNA therapeutics Market
9.4.3. Japan mRNA therapeutics Market
9.4.4. Australia mRNA therapeutics Market
9.4.5. South Korea mRNA therapeutics Market
9.4.6. Rest of Asia Pacific mRNA therapeutics Market
9.5. Latin America mRNA therapeutics Market Snapshot
9.5.1. Brazil mRNA therapeutics Market
9.5.2. Mexico mRNA therapeutics Market
9.6. Rest of The World mRNA therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Moderna, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Application Summary
10.2.1.5. Recent Developments
10.2.2. Biontech Se
10.2.3. Centogene Ag
10.2.4. Arcturus Therapeutics
10.2.5. Translate Bio, Inc.
10.2.6. GSK Plc.
10.2.7. Argos Therapeutics Inc.
10.2.8. Sangamo Therapeutics, Inc.
10.2.9. Avrobio, Inc.
10.2.10. Pfizer Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global mRNA therapeutics Market, report scope
TABLE 2. Global mRNA therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global mRNA therapeutics Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 4. Global mRNA therapeutics Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 5. Global mRNA therapeutics Market estimates & forecasts by End-User 2018-2028 (USD Billion)
TABLE 6.
TABLE 7. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global mRNA therapeutics Market
TABLE 57. List of primary sources, used in the study of global mRNA therapeutics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
TABLE 1. Global mRNA therapeutics Market, report scope
TABLE 2. Global mRNA therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global mRNA therapeutics Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 4. Global mRNA therapeutics Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 5. Global mRNA therapeutics Market estimates & forecasts by End-User 2018-2028 (USD Billion)
TABLE 6.
TABLE 7. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global mRNA therapeutics Market
TABLE 57. List of primary sources, used in the study of global mRNA therapeutics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
LIST OF FIGURES
FIG 1. Global mRNA therapeutics Market, research methodology
FIG 2. Global mRNA therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global mRNA therapeutics Market, key trends 2021
FIG 5. Global mRNA therapeutics Market, growth prospects 2022-2028
FIG 6. Global mRNA therapeutics Market, porters 5 force model
FIG 7. Global mRNA therapeutics Market, pest analysis
FIG 8. Global mRNA therapeutics Market, value chain analysis
FIG 9. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global mRNA therapeutics Market, regional snapshot 2018 & 2028
FIG 15. North America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 16. Europe mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 18. Latin America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 19. Global mRNA therapeutics Market, company market share analysis (2021)
FIG 1. Global mRNA therapeutics Market, research methodology
FIG 2. Global mRNA therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global mRNA therapeutics Market, key trends 2021
FIG 5. Global mRNA therapeutics Market, growth prospects 2022-2028
FIG 6. Global mRNA therapeutics Market, porters 5 force model
FIG 7. Global mRNA therapeutics Market, pest analysis
FIG 8. Global mRNA therapeutics Market, value chain analysis
FIG 9. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global mRNA therapeutics Market, regional snapshot 2018 & 2028
FIG 15. North America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 16. Europe mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 18. Latin America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 19. Global mRNA therapeutics Market, company market share analysis (2021)
